1. Short title This Act may be cited as the Biomedical Innovation Expansion Act of 2019 . 2. Reauthorization of NIH innovation proj­ects (a) Transfers Section 1001(b)(2)(A) of the 21st Century Cures Act ( Public Law 114–255 ) is amended by striking clauses (v) through (x) and inserting the following: (v) For fiscal year 2021, $854,000,000. (vi) For fiscal year 2022, $1,051,000,000. (vii) For fiscal year 2023, $1,345,000,000. (viii) For fiscal year 2024, $1,271,000,000. (ix) For fiscal year 2025, $1,301,000,000. (x) For fiscal year 2026, $1,306,000,000. (xi) For fiscal year 2027, $1,336,000,000. (xii) For fiscal year 2028, $1,376,000,000. (xiii) For fiscal year 2029, $1,436,000,000. (xiv) For fiscal year 2030, $1,469,000,000. . (b) Authorization of appropriations Section 1001(b)(3)(A) of the 21st Century Cures Act ( Public Law 114–255 ) is amended by striking 2026 and inserting 2030 . (c) Offsetting future appropriations Section 1001(b)(3)(B) of the 21st Century Cures Act ( Public Law 114–255 ) is amended by striking 2026 and inserting 2030 . (d) NIH innovation projects Section 1001(b)(4) of the 21st Century Cures Act ( Public Law 114–255 ) is amended— (1) in the matter preceding subparagraph (A), by striking 2026 and inserting 2030 ; (2) in subparagraph (A)— (A) in the matter preceding clause (i), by striking $1,455,000,000 and inserting $4,413,000,000 ; and (B) by striking clauses (v) through (x) and inserting the following: (v) For fiscal year 2021, $209,000,000. (vi) For fiscal year 2022, $300,000,000. (vii) For fiscal year 2023, $419,000,000. (viii) For each fiscal years 2024 through 2030, $430,000,000. ; (3) in subparagraph (B)— (A) in the matter preceding clause (i), by striking $1,511,000,000 and inserting $4,428,000,000